Back

Apixaban successfully resolved left atrial appendage thrombus in patients with end stage renal disease with dialysis

28 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Clinical Cases - Atrial Fibrillation - Pathophysiology and Mechanisms Pathophysiology and Mechanisms HFA Premium Access Heart Failure 2018

About the speaker

Photo
Professor Yae Min Park

Gachon University Gil Medical Center, Incheon (Korea (Republic of))

Access the full session

Session thumbnail
Poster Session 3 - Clinical Cases - Atrial Fibrillation - Pathophysiology and Mechanisms

The Event

Event poster

Heart Failure 2018

28 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Comparative analysis of oral anticoagulation therapy in Asian patients with atrial fibrillation and end-stage renal disease: a nationwide population-based cohort study
28 August 2023
thumbnail
Congress Presentation
Clinical risk prediction for left atrial appendage thrombus among patients with atrial fibrillation
27 August 2022
thumbnail
Congress Session
Don’t forget to look right
18 May 2025
thumbnail
Congress Presentation
Apixaban versus Warfarin in Patients with Left Ventricular (LV) Thrombus, a prospective randomized trial
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources